About Phibro Animal Health Corp. 
Phibro Animal Health Corp.
Pharmaceuticals & Biotechnology
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
Company Coordinates 
Company Details
300 Frank W Burr Blvd Ste 21 Fl 3 , TEANECK NJ : 07666
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 60 Schemes (48.84%)
Foreign Institutions
Held by 85 Foreign Institutions (7.85%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Jack Bendheim
Chairman of the Board, President, Chief Executive Officer, Director
Mr. Jonathan Bendheim
Director and President, MACIE Region and General Manager of Israel Operations
Mr. Daniel Bendheim
Executive Vice President, Corporate Strategy and Director
Mr. Gerald Carlson
Independent Director
Mr. E. Thomas Corcoran
Independent Director
Mr. Sam Gejdenson
Independent Director
Ms. Mary Malanoski
Independent Director
Ms. Carol Wrenn
Independent Director
Revenue and Profits:
Net Sales:
379 Million
(Quarterly Results - Jun 2025)
Net Profit:
17 Million
Pharmaceuticals & Biotechnology
USD 1,598 Million (Small Cap)
21.00
NA
1.22%
2.28
18.91%
5.59






